Jason Roberts, BPharm(Hons), PhD, FSHP, FISAC

Professor & NHMRC Practitioner Fellow
The University of Queensland, Australia

Disclosure(s): British Society of Chemotherapy: Grant/Research Support; Cipla: Honoraria; Gilead: Advisor/Consultant; MSD: Advisor/Consultant, Honoraria; Pfizer: Board Member, Honoraria; Qpex: Grant/Research Support; Sandoz: Board Member; Summit: Advisor/Consultant; Wolters Kluwer: Advisor/Consultant

Professor Jason Roberts is a Clinical Pharmacist at Royal Brisbane and Women’s Hospital and an Australian National Health and Medical Research Council Leadership Fellow at The University of Queensland. He is Acting Director of the University of Queensland Centre for Clinical Research as well as Interim Director of the Herston Infectious Diseases Institute (HeIDI). He also leads the Centre of Research Excellence RESPOND which aims to develop optimised antibiotic dosing regimens to improve patient outcomes and minimise the emergence of antibiotic-resistant superbugs.

Poster(s):

• 216 - A Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of the Beta-lactamase inhibitor Xeruborbactam Alone and in Combination Meropenem in Healthy Adult Subjects
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET

• 218 - A Phase 1 Study of the Single-Dose Safety, Tolerability, and Pharmacokinetics of the Beta-lactamase inhibitor Xeruborbactam Administered as the Isobutyryloxymethyl Oral Prodrug to Healthy Adult Subjects
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET